Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesFebruary 24, 2026
FDA Issues Plausible Mechanism Pathway Draft Guidance to Spur Innovation for Individualized TherapiesFebruary 24, 2026
DNA & Genetics Tamarind Bio Secures $13.6M Series A to Make AI More Accessible for BiologyBy adminFebruary 24, 20260 Tamarind co-founders: Sherry Liu and Deniz Kavi [Tamarind] The year was 2024. Deniz Kavi, a software engineer at Stanford School…
